BlackRock’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
225,605
-562,000
| -71% | -$3.12M | ﹤0.01% | 4113 |
|
|
2025
Q1 | $3.39M | Sell |
787,605
-20,481
| -3% | -$88.1K | ﹤0.01% | 3753 |
|
|
2024
Q4 | $17.3M | Buy |
808,086
+8,058
| +1% | +$172K | ﹤0.01% | 3089 |
|
|
2024
Q3 | $15M | Buy |
800,028
+107,048
| +15% | +$2.01M | ﹤0.01% | 3163 |
|
|
2024
Q2 | $15.7M | Buy |
692,980
+499,558
| +258% | +$11.3M | ﹤0.01% | 3081 |
|
|
2024
Q1 | $5.68M | Buy |
193,422
+61,025
| +46% | +$1.79M | ﹤0.01% | 3561 |
|
|
2023
Q4 | $1.04M | Buy |
132,397
+319
| +0.2% | +$2.52K | ﹤0.01% | 4165 |
|
|
2023
Q3 | $925K | Sell |
132,078
-1,157
| -0.9% | -$8.1K | ﹤0.01% | 4205 |
|
|
2023
Q2 | $1.83M | Buy |
133,235
+7,583
| +6% | +$104K | ﹤0.01% | 4003 |
|
|
2023
Q1 | $2.27M | Buy |
125,652
+104,240
| +487% | +$1.89M | ﹤0.01% | 3918 |
|
|
2022
Q4 | $103K | Buy |
21,412
+109
| +0.5% | +$526 | ﹤0.01% | 4951 |
|
|
2022
Q3 | $168K | Sell |
21,303
-504
| -2% | -$3.98K | ﹤0.01% | 4934 |
|
|
2022
Q2 | $421K | Buy |
21,807
+4,850
| +29% | +$93.6K | ﹤0.01% | 4737 |
|
|
2022
Q1 | $603K | Buy |
16,957
+8
| +0% | +$284 | ﹤0.01% | 4740 |
|
|
2021
Q4 | $1.33M | Buy |
+16,949
| New | +$1.33M | ﹤0.01% | 4495 |
|